Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bartolomeo Bosco"'
Autor:
Helena Ramos, Maria I.L. Soares, Joana Silva, Liliana Raimundo, Juliana Calheiros, Célia Gomes, Flávio Reis, Filipe A. Monteiro, Cláudia Nunes, Salette Reis, Bartolomeo Bosco, Silvano Piazza, Lucília Domingues, Petr Chlapek, Petr Vlcek, Pavel Fabian, Ana Teresa Rajado, A.T.P. Carvalho, Renata Veselska, Alberto Inga, Teresa M.V.D. Pinho e Melo, Lucília Saraiva
Publikováno v:
Cell Reports, Vol 35, Iss 2, Pp 108982- (2021)
Summary: Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53 activity has become one of the most appealing anticancer therapeutic strategies. Here, we disclose the p53-activating anticancer drug (3S)-6,7-bis(hyd
Externí odkaz:
https://doaj.org/article/49516e7fa22e429b9dc9fbabff3cfc73
Autor:
Bartolomeo Bosco, Andrea Defant, Andrea Messina, Tania Incitti, Denise Sighel, Angela Bozza, Yari Ciribilli, Alberto Inga, Simona Casarosa, Ines Mancini
Publikováno v:
Molecules, Vol 23, Iss 8, p 1996 (2018)
Reversine is a potent antitumor 2,6-diamino-substituted purine acting as an Aurora kinases inhibitor and interfering with cancer cell cycle progression. In this study we describe three reversine-related molecules, designed by docking calculation, tha
Externí odkaz:
https://doaj.org/article/a629fbde81044463accd1d6981e783e6
Autor:
Dario Rizzotto, Alicia Perzolli, Bartolomeo Bosco, Alessandra Bisio, Meriem Hadjer Hamadou, Frédéric Catez, Erik Dassi, Angeline Gaucherot, Jean-Jacques Diaz, Sebastiano Giorgetta, Alberto Inga, Annalisa Rossi, Francesco Bonollo
Publikováno v:
Cancers
Volume 13
Issue 17
Cancers, MDPI, 2021, 13, ⟨10.3390/cancers13174412⟩
Cancers, Vol 13, Iss 4412, p 4412 (2021)
Volume 13
Issue 17
Cancers, MDPI, 2021, 13, ⟨10.3390/cancers13174412⟩
Cancers, Vol 13, Iss 4412, p 4412 (2021)
Simple Summary Translation occurs in the cell both through cytoplasmic and mitochondrial ribosomes, respectively translating mRNAs encoded by the nuclear and the mitochondrial genome. Here we found that the silencing of DHX30, an RNA-binding protein
Autor:
Lucília Domingues, Teresa M. V. D. Pinho e Melo, Bartolomeo Bosco, Helena Ramos, Célia Gomes, Flávio Reis, Ana Teresa Rajado, Lucília Saraiva, Pavel Fabian, Petr Vlcek, Filipe Monteiro, Cláudia Nunes, Alberto Inga, Maria I. L. Soares, Renata Veselská, Silvano Piazza, Joana Silva, Juliana Calheiros, Alexandra T. P. Carvalho, Petr Chlapek, Liliana Raimundo, Salette Reis
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Cell Reports, Vol 35, Iss 2, Pp 108982-(2021)
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Cell Reports, Vol 35, Iss 2, Pp 108982-(2021)
Impairment of the p53 pathway is a critical event in cancer. Therefore, reestablishing p53 activity has become one of the most appealing anticancer therapeutic strategies. Here, we disclose the p53-activating anticancer drug (3S)-6,7-bis(hydroxymethy
Autor:
Dario Rizzotto, Alicia Perzolli, Erik Dassi, Angeline Gaucherot, Frédéric Catez, Sebastiano Giorgetta, Jean-Jacques Diaz, Bartolomeo Bosco, Alberto Inga, Annalisa Rossi, Francesco Bonollo
DHX30 was recently implicated in the translation control of mRNAs involved in p53-dependent apoptosis. Here we show that DHX30 exhibits a more general function by integrating the activities of its cytoplasmic isoform and of the more abundant mitochon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbbfe48cd78594e8443bef2a812f2916
https://doi.org/10.1101/2020.07.13.196709
https://doi.org/10.1101/2020.07.13.196709
Publikováno v:
Journal of Visualized Experiments.
The finding that the well-known mammalian P53 protein can act as a transcription factor (TF) in the yeast S. cerevisiae has allowed for the development of different functional assays to study the impacts of 1) binding site [i.e., response element (RE
Autor:
Alessandra Bisio, Bartolomeo Bosco, Helena Ramos, Flávio Reis, Carla Cristina Marques de Oliveira, Alberto Inga, Maria Inês Almeida, Célia Gomes, Silvano Piazza, Maria M. M. Santos, Lucília Domingues, Lucília Saraiva, Liliana Raimundo, Matthias R. Bauer, Alan R. Fersht, Sara Gomes, Joana Soares, Nair Nazareth, Joao Paulo Bras, Joana B. Loureiro, Valentina Barcherini
Publikováno v:
Cancers, Vol 11, Iss 8, p 1151 (2019)
Cancers
Cancers; Volume 11; Issue 8; Pages: 1151
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Cancers
Cancers; Volume 11; Issue 8; Pages: 1151
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Half of human cancers harbor TP53 mutations that render p53 inactive as a tumor suppressor. In these cancers, reactivation of mutant p53 (mutp53) through restoration of wild-type-like function constitutes a valuable anticancer therapeutic strategy. I
Autor:
Joaquín M. Espinosa, Erik Dassi, Sara Zaccara, Bartolomeo Bosco, Zdenek Andrysik, Annalisa Rossi, Matthew D. Galbraith, Alessandro Quattrone, Alberto Inga, Dario Rizzotto
Publikováno v:
ESMO Open. 3:A50-A51
Introduction The transcription factor p53 can be efficiently activated by the small molecule Nutlin-3 without inducing genotoxic stress. Treatment of different cell lines with this small molecule can result in different phenotypes, ranging from cell
Autor:
Yari Ciribilli, Tania Incitti, Angela Bozza, Andrea Messina, Bartolomeo Bosco, Denise Sighel, Alberto Inga, Andrea Defant, Ines Mancini, Simona Casarosa
Publikováno v:
Molecules
Volume 23
Issue 8
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, Vol 23, Iss 8, p 1996 (2018)
Volume 23
Issue 8
Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules, Vol 23, Iss 8, p 1996 (2018)
Reversine is a potent antitumor 2,6-diamino-substituted purine acting as an Aurora kinases inhibitor and interfering with cancer cell cycle progression. In this study we describe three reversine-related molecules, designed by docking calculation, tha